Si L. Luo
About Si L. Luo
Si L. Luo is the CEO of CareXM, having held the position since 2022. He has extensive experience in the healthcare technology sector, previously serving as President and CEO of PatientSafe Solutions and Vice President at Vocera Communications.
Current Role at CareXM
Si L. Luo serves as the CEO of CareXM, a position he has held since 2022. In this role, he is responsible for leading the company's strategic direction and overseeing its operations. His experience in the healthcare technology sector informs his leadership approach, as he focuses on enhancing patient care through innovative solutions.
Previous Experience at PatientSafe Solutions
Prior to his current role, Si L. Luo was the President and CEO of PatientSafe Solutions from 2016 until its acquisition by Vocera in May 2021. During his tenure, he led the company in developing healthcare communication solutions, contributing to its growth and market presence. He also held various positions at PatientSafe Solutions, including Commercial Operations and Product roles, from 2009 to 2016.
Career Background in Finance and Analysis
Si L. Luo began his career as an Analyst at Macquarie Bank from 2008 to 2009. He also worked as a Project Manager at Growthink from 2005 to 2006 and served as a Research Analyst at The Lancer Group from 2006 to 2007. His early experience in finance and project management provided a foundation for his later roles in the healthcare technology sector.
Educational Background in Bioengineering and Management Science
Si L. Luo studied at UC San Diego, where he focused on Bioengineering and Management Science. This educational background equips him with a unique blend of technical and managerial skills, which he applies in his leadership roles within the healthcare industry.
Experience at Vocera Communications
After his time at PatientSafe Solutions, Si L. Luo worked as Vice President of Vocera Edge at Vocera Communications from 2021 to 2022. His role involved overseeing product development and strategic initiatives following Vocera's acquisition by Stryker in early 2022.